This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: News
Check out our new article: ‘Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines’ – OPEN ACCESS
May 30, 2024Borrajo, M.L., Lou, G., Anthiya, S. et al. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01635-5
Read More
Check out our new OPEN ACCESS publication: ‘Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium’
March 13, 2024Marcos-Villar, L., Perdiguero, B., Anthiya, S. et al. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium. npj Vaccines 9, 53 (2024). https://doi.org/10.1038/s41541-024-00838-8.
Read More
Grand Challenges in Global Health Annual Meeting 2023
October 9, 2023Outstanding Grand Challenges Annual Meeting 2023, hosted by the Bill & Melinda Gates Foundation in Dakar
Read More
Desarrollo de nanoterapias para la prevención y tratamiento de COVID-19 (NANODCOV)
August 25, 2023Expediente: IN852 2021/16
Título: Desarrollo de nanoterapias para la prevención y tratamiento de COVID-19 (NANODCOV)
Miembros del Consorcio: Smart Vitamins, Universidad de Santiago de Compostela (USC), Fundación Instituto de Investigación Sanitario de Santiago de Compostela (FIDIS)
María José Alonso’s Lab participates in the NOSEVAC Consortium, a new European collaboration to develop nasal vaccines
June 14, 2023María José Alonso’s and Noemi Csaba’s research groups at the Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) of the University of Santiago de Compostela (USC) will participate in the NOSEVAC Consortium, a new European collaboration to develop nasal vaccines.
Read More
Check out our new OPEN ACCESS publication: ‘Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors’
March 29, 2023Shubaash Anthiya, Süleyman Can Öztürk, Hamdullah Yanik, Ece Tavukcuoglu, Adem Şahin, Dhrubajyoti Datta, Klaus Charisse, David Moreira Álvarez, María Isabel Loza, Alfonso Calvo, Einar Sulheim, Simon Loevenich, Geir Klinkenberg, Ruth Schmid, Muthiah Manoharan, Güneş Esendağlı, Maria Jose Alonso, ‘Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors’, Journal of Controlled Release.
Read More
MJ Alonso’s Lab Mini-Congress 2022
December 31, 2022The Alonso’s Lab mini-congress is an annual event aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work.
Read More
MJ Alonso’s Lab wishes you a happy New Year!
December 31, 2022Happy New Year to everyone! We wish you a fabulous 2023, full of great experiences and achievements in science.
Read More
María José Alonso receives the “Doctora de Alcalá” Award from the University of Alcalá de Henares
December 16, 2022The Spanish Forum of Innovative Companies – Foro Español de Empresas Innovadoras (FEI) has distinguished María José Alonso in its annual awards in the category of ‘Researcher / Innovator 2022’
Read More
María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin
December 2, 2022This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.
Read More